Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Alexandria Hammond Initiated (AKRO) at Hold and Held Target at $30 on, Apr 22nd, 2024
Alexandria Hammond of B of A Securities, Initiated "Akero Therapeutics, Inc." (AKRO) at Hold and Held Target at $30 on, Apr 22nd, 2024.
Alexandria has made no other calls on AKRO in the last 4 months.
There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Alexandria's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Alexandria
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Tuesday, March 5th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, March 5th, 2024
